COVID-19  Health Evidence Summary No.65 by MIllington, Kerry & Reddin, Samantha







Health Evidence Summary No.65 
Kerry Millington & Samantha Reddin 
Liverpool School of Tropical Medicine (LSTM) & Institute of Development Studies 
17 June 2020  
 
This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. It is a result of 3 hours of work and is not intended to be a comprehensive summary 
of available evidence on COVID-19 but aims to make original documents easily accessible to 
decision makers which, if relevant to them, they should go to before making decisions.   


























 A study of more than 40 
000 individuals to assess 
contact patterns and 
potential SARS-CoV-2 
transmission in different 
settings and to compare 
how combinations of self-
isolation, contact tracing, 
and physical distancing 
could reduce secondary 
cases. 
 The high transmissibility, 





effective isolation and 
contract tracing. This 
analysis estimated that a 
high proportion of cases 
would need to self-isolate 
and a high proportion of 
their contacts to be 
successfully traced to 









lower than 1 in the 
absence of other 
measures. 
 Combining isolation and 
contact tracing with 
physical distancing 
measures, especially in 
settings where contact 
tracing would be difficult, 
could increase the 
likelihood of achieving 
sustained control of 
SARS-CoV-2 
transmission 












 Using a dynamic model 
of SARS-CoV-2 
transmission, authors 
simulated how a C19 
outbreak could spread 
within the expansion site 
according to 3 possible 
transmission scenarios 
(high, moderate, low) 
 Results show that a large 
scale outbreak is very 
likely in this setting after 
a single infectious person 
enters the camp 
 Hospitalisation capacity 
may be exceeded within 
55-136 days after 
introduction 
 Many approaches used 
to prevent and respond 
to C19 will not be 
practical in humanitarian 
settings. Novel and 
untested strategies 
should be considered 
including innovative 














PLoS ONE | 
Article 
 Authors claim that this 
model can be used far 
more effectively than 
current models to 
estimate the CFR during 
an outbreak, allow for 
better planning and to 
better understand the 
impact of individual 
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 Treatment as well 
tolerated 
 Confirmation of this 
first preliminary 
evidence of a 
treatment effect of 
GM-CSF inhibition 
in COVID-
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role in COVID-19 
vaccine development 
and access 




Social, political, and 
public health factors 
fuelling the COVID19 
crisis in Brazil and 
Colombia 








Online course 1 hour WHO 
16.06.2020 Africa beyond COVID-
19 






Nursing in Times of 
Crisis 
Online course 2 weeks – 
2 hours per 
week 




WHO Academy and 
WHO Info mobile 
applications 






















Webinar 1 hour WHO & ISQua – Dr 
Shams Syed, Dr Peter 
Lachman, Dr Teri 
Rynolds & Dr Ed Kelley 




5 hours Johns Hopkins 
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online brief with Dr 
David Nabarro 
Event 1h 4SD 
30.04.2020 Professor Chris 
Whitty’s Gresham 
lecture on COVID-19 
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Rapid review methodology 
The rapid daily search for peer-reviewed literature is carried out through a PubMed search with the following 
keywords (“COVID-19” OR “severe acute respiratory syndrome coronavirus 2” OR “2019-nCoV” OR “SARS-CoV-
2” OR “2019nCoV” OR “coronavirus” ) AND (“Africa”) OR (“equity” OR “equities”) OR (“poverty”), restricted to 
articles published in the previous 2 to 3 days, in English. This is complemented by a search of the homepage of 
the following high-impact global health journals: The Lancet journals, New England Journal of Medicine, Nature, 
JAMA, Annals of Internal Medicine, Cochrane Reviews, BMJ Global Health, the PLoS journals and a Twitter 
search of their Twitter pages. A search also of preprints from bioRxiv and medRxiv. Please note that papers that 
have not been peer-reviewed are highlighted in red. All primary research papers that relate to the primary and 
secondary impacts of the COVID-19 response in LMICs, and disease control and health system responses are 
included. Articles related to tackling the secondary impacts on other sectors are not included. Additional 
commentaries, opinions, and commissioned pieces are selected based on relevance. 
The search for dashboards, guidelines, tools, editorials, comments, blogs, opinions and news is through the 
academic journals listed above, C19 resource hubs and following lead academics and professionals on Twitter. 
About this report 
This daily COVID-19 health evidence summary (HES) is based on 3 hours of desk-based research. The 
summary is not intended to be a comprehensive summary of available evidence on COVID-19 but aims to make 
original documents easily accessible to decision makers which, if relevant to them, they should go to before 
making decisions. The HES are not intended to replace medical or professional advice and the researcher or the 
K4D consortium cannot be held responsible for any decisions made about COVID-19 on the basis of the HES 
12 
alone. K4D services are provided by a consortium of leading organisations working in international development, 
led by the Institute of Development Studies (IDS), with Education Development Trust, Itad, University of Leeds 
Nuffield Centre for International Health and Development, Liverpool School of Tropical Medicine (LSTM), 
University of Birmingham International Development Department (IDD) and the University of Manchester 
Humanitarian and Conflict Response Institute (HCRI). 
This evidence summary was prepared for the UK Government’s Department for 
International Development (DFID) and its partners in support of pro-poor programmes. 
It is licensed for non-commercial purposes only. K4D cannot be held responsible for 
errors, omissions or any consequences arising from the use of information contained in 
this health evidence summary. Any views and opinions expressed do not necessarily 
reflect those of DFID, K4D or any other contributing organisation.  
© DFID - Crown copyright 2020. 
 
